Abstract:Since the early 1980s when MRI imaging technology was put into clinical use, the number of MRI clinical tests has steadily increased by more than 10% every year. At the same time, exogenous MRI contrast agents have also been developed with the development of MRI technology. However, there are still challenges in the preparation of contrast agents for magnetic resonance imaging, such as how to prepare high-efficiency contrast agents with high stability and low biological toxicity. In order to study the contrast agent with simple preparation method, low cost, and good imaging effect, a magnetic resonance contrast agent was prepared by magnetic nanoparticles. By acting on magnetic resonance imaging detection method, and using polymer ligands to synthesize magnetic nanoparticles, experiments and tests of P(MA-alt-VAc) polymer ligand-modified magnetic nanoparticles were carried out. The experimental results showed that when nanoparticles containing different iron ion concentrations were incubated with DC 2.4 normal cells for 48 hours, the cell viability was still higher than 80% at concentrations up to 200 μm. It shows that the nanoparticle has high cell activity and good biological adaptability. The transverse relaxation ( r 2 ) value of the nanoparticles in aqueous solution at 37°C and 1.5 T magnetic field is 231.1 m-1 s-1, which is much higher than that of PTMP-PMAA ( r 2 = 35.1 mM-1 s-1), which is also more than five times the relaxation of SHU-555C ( r 2 = 44 mM-1 s-1). It shows that the nanoparticles prepared in this paper have good effect and can be used as a contrast agent in human brain for magnetic resonance imaging.

Synthesis and Relaxivity of Polyamide Paramagnetic Metal Complexes for Magnetic Resonance Imaging

Synthesis of Magnetic Resonance Imaging Contrast Agent with Tethered Quaternary Ammonium Group

Nmr Studies of Gd(Dtpa-Bin) in Human Serum Albumin Solution

Synthesis and the Magnetic Properties of Novel Metal (ii) Complexes of Polyamides

Hyperbranched Polyethylenimine Based Polyamine-N-Oxide-Carboxylate Chelates of Gadolinium for High Relaxivity Mri Contrast Agents

Chemical Synthesis of Paramagnetic Complexes

Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents

A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

Synthesis and Magnetic Properties of Poly(Amic Acid) Complexes Containing 1,10-Phenanthroline

Synthesis and Evaluation of Bingel-Hirsch Multiadducts of Paramagnetic Gadofullerene As Potential Magnetic Resonance Imaging Contrast Agents.

Magnetic Resonance Neuroimaging Contrast Agents of Nanomaterials

Progress in MRI Contrast Agent Ligands Modified by Macromolecules

Development of Magnetic Resonance Imaging Contrast Agents with PAMAM Dendrimer Cores

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

The r1 relaxivity and T1 imaging properties of dendrimer-based manganese and gadolinium chelators in magnetic resonance imaging

Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Functional polymers as metal-free magnetic resonance imaging contrast agents

HP-DO3A-based Amphiphilic MRI Contrast Agents and Relaxation Enhancement Through Their Assembly with Polyelectrolytes.

High-relaxivity MRI contrast agents prepared from miniemulsion polymerization using gadolinium(III)-based metallosurfactants.

Gadolinium Complexes of Macrocyclic Diethylenetriamine-N-oxide Pentaacetic Acid-Bisamide As Highly Stable MRI Contrast Agents with High Relaxivity.